# Alzheimer's Supplement: Vanderbilt Diabetes Research and Training Center

> **NIH NIH P30** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2021 · $432,500

## Abstract

In response to NOT-AG-20-034 (Alzheimer's-focused administrative supplements for NIH grants that are not
focused on Alzheimer's disease), the Vanderbilt Diabetes Research and Training Center (DRTC, P30;
DK20593) proposes to expand their long-standing efforts to discover, apply, and translate scientific knowledge
about diabetes, obesity, and metabolism to now include research at the intersection of Alzheimer's Disease
and related dementias (ADRD) and diabetes. Specifically, we will establish a Pilot and Feasibility (P&F)
program that will encourage and allow Vanderbilt investigators who are not currently working on ADRD to
initiate ADRD-related research. We will be assisted by a strong collaboration with the Vanderbilt Memory and
Alzheimer's Center (VMAC) that houses an interdisciplinary team of scientists and clinicians committed to
discovering the root cause of Alzheimer's disease. We propose two aims: 1) Establish a Pilot and Feasibility
(P&F) Program that fosters collaborative, interdisciplinary research on ADRD by diabetes-related investigators.
By leveraging Vanderbilt's more than 25-year experience overseeing a NIDDK-supported diabetes-related P&F
program, we will solicit P&F grant applications from Vanderbilt scientists who are not working on ADRD. P&F
proposals will focus on ADRD-related research and encourage multidisciplinary collaborations with a focus on
the connection of diabetes or obesity and ADRD. 2) Use P&F-funded investigators and grants to facilitate and
enhance interactions other investigators in the DRTC and VMAC. To amplify the impact of the research
supported by the P&F grants, we will invite the P&F grant awardees plus other investigators and scientists
working in related areas to attend a Collaborative Research Symposium focused on the intersection of
diabetes and ADRD. With the goal of facilitating interactions, building future collaborations, and sustaining the
impact of P&F program, we will especially work to involve investigators and trainees. Through these efforts the
Pilot and Feasibility (P&F) Program will promote research at the intersection of ADRD and diabetes or obesity.

## Key facts

- **NIH application ID:** 10292538
- **Project number:** 3P30DK020593-44S1
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** ALVIN C POWERS
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $432,500
- **Award type:** 3
- **Project period:** 1996-12-01 → 2022-07-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10292538

## Citation

> US National Institutes of Health, RePORTER application 10292538, Alzheimer's Supplement: Vanderbilt Diabetes Research and Training Center (3P30DK020593-44S1). Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/grant/nih/10292538. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*